SARS-CoV-2-specific T cells are generated in less than half of allogeneic HSCT recipients failing to seroconvert after COVID-19 vaccination
在接受异基因造血干细胞移植(HSCT)且接种新冠疫苗后未发生血清转化的患者中,仅有不到一半的人体内能产生SARS-CoV-2特异性T细胞。
期刊:European Journal of Immunology
影响因子:3.7
doi:10.1002/eji.202149771
Jarisch, Andrea; Wiercinska, Eliza; Daqiq-Mirdad, Shabnam; Hellstern, Helen; Ajib, Salem; Cremer, Anjali; Nguyen, Ngoc Thien Thu; Dukat, Alexandra; Ullrich, Evelyn; Ciesek, Sandra; Chow, Kai-Uwe; Serve, Hubert; Seifried, Erhard; Bader, Peter; Bonig, Halvard; Bug, Gesine
干细胞
微生物学
T细胞
T细胞
SARS-CoV-2
发育与干细胞
免疫/内分泌
新冠
细胞生物学